(Q42988688)

12 November 2017

title

Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. (English)

1 reference

12 November 2017

1 reference

Kaserer K

1

1 reference

12 November 2017

Fiedler R

2

1 reference

12 November 2017

Steindl P

3

1 reference

12 November 2017

Müller CH

4

1 reference

12 November 2017

Wrba F

5

1 reference

12 November 2017

Ferenci P

6

1 reference

12 November 2017

publication date

1 May 1998

1 reference

12 November 2017

1 reference

12 November 2017

volume

32

1 reference

12 November 2017

issue

5

1 reference

12 November 2017

page(s)

454-461

1 reference

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Chronic hepatitis C. Advances in diagnostic testing and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Hepatitis C serotype and response to interferon therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Classification of chronic viral hepatitis: a need for reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Dose increase augments response rate to interferon-alpha in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Iron and chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Serum ferritin as a predictor of host response to hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Hepatitis B virus infection markers in genetic haemochromatosis. A study of 272 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Iron status and cellular immune competence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

Role of influenza B virus in hepatic steatosis and mitochondrial abnormalities in a mouse model of Reye syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00413.X

10.1046/J.1365-2559.1998.00413.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference